Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization

Microbiology

Volumn 154, Issue 2, 2008, Pages 619-632

  Cote, C K ^a   Bozue, J ^a   Moody, K L ^a   DiMezzo, T L ^a   Chapman, C E ^a   Welkos, Susan L ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; SPORE OPSONIZATION ASSOCIATED ANTIGEN A; UNCLASSIFIED DRUG;

AMES TEST; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE FUNCTION; GENE SEQUENCE; IMMUNOELECTRON MICROSCOPY; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL PROTEINS; BASE SEQUENCE; EPITOPES; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; MUTATION; PHAGOCYTOSIS; RABBITS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPORES, BACTERIAL; VIRULENCE;

BACILLI (CLASS); BACILLUS ANTHRACIS; BACILLUS CEREUS GROUP;

EID: 39749133666     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/008292-0     Document Type: Article

References (67)

1. F of Bacillus subtilis by using random-sequence oligonucleotides. J Bacteriol 183, 3623-3630.
2. Banks, D. J., Barnajian, M., Maldonado-Arocho, F. J., Sanchez, A. M. & Bradley, K A. (2005). Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol 7, 1173-1195.
3. Bhatnagar, R. & Batra, S. (2001). Anthrax toxin. Crit Rev Microbiol 27, 167-200.
4. Bozue, J. A., Parthasarathy, N., Phillips, L. R., Cote, C. K., Fellows, P. F., Mendelson, I., Shafferman, A. & Friedlander, A. M. (2005). Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb Pathog 38, 1-12.
5. Bozue, J., Cote, C. K., Moody, K. L. & Welkos, S. L. (2007). Fully virulent Bacillus anthracis does not require the immunodominant protein, BclA, for pathogenesis. Infect Immun 75, 508-511.
6. Brachman, P. S., Gold, H, Plotkin, S. A., Fekety, F. R., Werrin, M. & Ingraham, N. R. (1962). Field evaluation of a human anthrax vaccine. Am J Public Health 52, 632-645.
7. Brossier, F. & Mock M. (2001). Toxins of Bacillus anthracis. Toxicon 39, 1747-1755.
8. Brossier, F., Levy, M. & Mock M. (2002). Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun 70, 661-664.
9. Challacombe, J. F., Altherr, M. R., Xie, G., Bhotika, S. S., Brown, N., Bruce, D., Campbell, C. S., Campbell, M. L., Chen, J. & other authors (2007). The complete genome sequence of Bacillus thuringiensis Al Hakim. J Bacteriol 189, 3680-3681.
10. Clements, M. O. & Moir, A. (1998). Role of the gerI operon of Bacillus cereus 569 in the response of spores to germinants. J Bacteriol 180, 6729-6735.
11. Coburn, P. S., Hancock, L. E., Booth, M. C. & Gilmore, M. S. (1999). A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin. Infect Immun 67, 3339-3347.
12. Cohen, S., Mendelson, I., Altboum, Z., Kobiler, D., Elhanany, E., Bino, T., Leitner, M., Inbar, I., Rosenberg, H. & other authors (2000). Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 68, 4549-4558.
13. Cote, C. K., Rea, K. M., Norris, S. L., van Rooijen, N. & Welkos, S. L. (2004). The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37, 169-175.
14. Cote, C. K., Rossi, C. A., Kang, A. S., Morrow, P. R., Lee, J. S. & Welkos, S. L (2005). The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog 38, 209-225.
15. Cowan, A. E., Olivastro, E. M., Koppel, D. E., Loshon, C. A., Setlow, B. & Setlow, P. (2004). Lipids in the inner membrane of dormant Bacillus species are largely immobile. Proc Natl Acad Sci U S A 101, 7733-7738.
16. Day, W. A., Jr, Rasmussen, S. L., Carpenter, B. M., Peterson, S. N. & Friedlander, A. M. (2007). Microarray analysis of transposon insertion mutations in Bacillus anthracis: global identification of genes required for sporulation and germination. J Bacteriol 189, 3296-3301.
17. Enkhtuya, J., Kawamoto, K., Kobayashi, Y., Uchida, I., Rana, N. & Makino, S. (2006). Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Microbiology 152, 3103-3110.
18. Enkhtuya, J., Makino, S., Uchida, I. & Kawamoto, K. (2007). In reply - Microbiology Comment. Microbiology 153, 302-304.
19. Farchaus, J. W., Ribot, W. J., Jendrek, S. & Little, S. F. (1998). Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis. Appl Environ Microbiol 64, 982-991.
20. Fellows, P. F., Linscott, M. K., Ivins, B. E., Pitt, M. L., Rossi, C. A., Gibbs, P. H. & Friedlander, A. M. (2001). Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19, 3241-3247.
21. Friedlander, A. M. (2000). Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr Clin Top Infect Dis 20, 335-349.
22. Friedlander, A. M., Pittman, P. R. & Parker, G. W. (1999). Anthrax vaccine; evidence for safety and efficacy against inhalational anthrax. JAMA 282, 2104-2106.
23. Friedlander, A. M., Welkos, S. L. & Ivins, B. E. (2002). Anthrax vaccines. Curr Top Microbiol Immunol 271, 33-60.
24. Gardy, J. L., Spencer, C., Wang, K., Ester, M., Tusnády, G. E., Simon, I., Hua, S., deFays, K., Lambert, C. & other authors (2003). PSORT-B: improving protein subcellular localization prediction for Gram-negative bacteria. Nucleic Acids Res 31, 3613-3617.
25. Glomski, I. J., Corre, J. P., Mock, M. & Goossens, P. L. (2007). Cutting edge: IFN-γ-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol 178, 2646-2650.
26. Gominet, M., Slamti, L., Gilols, N., Rose, M. & Lereclus, D. (2001). Oligopeptide permease is required for expression of the Bacillus thuringiensis plcR regulon and for virulence. Mol Microbiol 40, 963-975.
27. Goodin, J. L., Raab, R. W., McKown, R. L., Coffman, G. L., Powell, B. S., Enama, J. T., Ligon, J. A. & Andrews, G. P. (2005). Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum. Protein Expr Purif 40, 152-163.
28. Goossens, P. L., Sylvestre, P. & Mock M. (2007). Of spore opsonization and passive protection against anthrax - Microbiology Comment. Microbiology 153, 301-302.
29. Hahn, U. K., Boehm, R. & Beyer, W. (2005). DNA vaccination against anthrax in mice - combination of anti-spore and anti-toxin components. Vaccine 24, 4569-4571.
30. Helmann, J. D. & Moran, C. P., Jr (2002). RNA polymerase and sigma factors. In Bacillus subtilis and its Closest Relatives. From Genes to cells, pp. 289-312. Edited by A. L. Sonenshein, J. A. Hoch & R. Losick. Washington, DC: American Society for Microbiology.
31. Jackson, P. J., Walthers, E. A., Kallf, A. S., Richmond, K. L., Adair, D. M., Hill, K. K., Kuske, C. R., Andersen, G. L., Wilson, K. H. & other authors (1997). Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates. Appl Environ Microbiol 63, 1400-1405.
32. Jedrzejas, M. J. (2002). The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: development of novel prophylactic and therapeutic agents. Crit Rev Biochem Mol Biol 37, 339-373.
33. Joellenbeck, L. M. & Hernandez, L. M. (2002). The Institute of Medicine's independent scientific assessment of Gulf War health issues. Mil Med 167, 186-190.
34. Johnson, Z. I. & Chisholm, S. W. (2004). Properties of overlapping genes are conserved across microbial genomes. Genome Res 14, 2268-2272.
35. Keim, P., Kalif, A., Schupp, J., Hill, K, Travis, S. E, Richmond, K., Adair, D. M., Hugh-Jones, M, Kuske, C. R. & Jackson, P. (1997). Molecular evolution and diversity in Bacillus anthracis as detected by amplified fragment length polymorphism markers. J Bacteriol 179, 818-824.
36. Kim, H.,,Hahn, M., Grabowski, P., McPherson, D. C, Otte, M. M., Wang, R., Ferguson, C. C., Eichenberger, P. & Driks, A. (2006). The Bacillus subtilis spore coat protein interaction network. Mol Microbiol 59, 487-502.
37. Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E. L. (2001). Predicting transmembrane,protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305, 567-580.
38. Kudva I. T., Griffin, R. W, Garren, J. M., Calderwood, S. B. & John, M. (2005). Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect Immun 73, 5685-5696.
39. Laflamme, C, Lavigne, S, Ho, J. & Duchaine, C. (2004). Assessment of bacterial endospore viability with fluorescent dyes. J Appl Microbiol 96, 684-692.
40. Lemon, K. P. & Grossman, A. D. (1998). Localization of bacterial DNA polymerase: evidence for a factory model of replication. Science 282, 1516-1519.
41. Lappla, S. H., Robbins, J. B, Schneerson, R. & Shiloach, J. (2002). Development of an improved vaccine for anthrax. J Clin Invest 110, 141-144.
42. Little, S. & Driks, A. (2001). Functional analysis of the Bacillus subtilis morphogenetic spore coat protein.CotE. Mol Microbiol 42, 1107-1120.
43. Little, S. F. & Knudson, G. B. (1986). Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect Immun 52, 509-512.
44. Little, S. F., Webster, W. M., Ivins, B. E, Fellows, P. F, Norris, S. L & Andrews, G. P. (2004). Development of an in vitro-based potency assay for anthrax vaccine. Vaccine 22, 2843-2852.
45. Mendelson, I., Tobery, S., Scorpio, A., Bozue, J., Shafferman, A. & Friedlander, A. M. (2004). The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulence. Microb Pathog 37, 149-154.
46. Moir, A., Corfe, B. M. & Behravan, J. (2002). Spore germination. Cell Mol Life Sci 59, 403-409.
47. Nicholson, W. L & Setlow, P. (1990). Sporulation, germination, and outgrowth. In Molecular Biological Methods for Bacillus, pp. 391-450. Edited by C. R. Harwood & S. M. Cutting. New York: Wiley.
48. Pagni, M., Ioannidis, V., Cerutti, L, Zahn-Zabal, M., Jongeneel, C. V. & Falquet, L (2004). MyHits: a new interactive resource for protein annotation and domain identification. Nucleic Acids Res 32, W332-W335.
49. Paidhungat, M. & Setlow, P. (1999). Isolation and characterization of mutations in Bacillus subtilis that allow spore germination in the novel germinant D-alanine. J Bacteriol 181, 3341-3350.
50. Pandey, N. K & Aronson, A. I. (1979). Properties of the Bacillus subtilis spore coat. J Bacteriol 137, 1208-1218.
51. Perez-Casal, J., Caparon, M. G. & Scott, J. R. (1991). Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol 173, 2617-2624.
52. Phillips, A. P. & Ezzell, J. W. (1989). Identification of Bacillus anthracis by polyclonal antibodies against extracted vegetative cell antigens. J Appl Bacteriol 66, 419-432.
53. Pittman, P. R., Kim-Ahn, G., Pifat, D. Y., Coonan, K., Gibbs, P., Little, S., Pace-Templeton, J. G., Myers, R., Parker, G. W. & Friedlander, A. M. (2002). Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 20, 1412-1420.
54. Popov, S. G., Popova, T. G., Grene, E., Klotz, F., Cardwell, J., Bradburne, C., Jama, Y., Maland, M., Wells, J. & other authors (2004). Systemic cytokine response in murine anthrax. Cell Microbiol 6, 225-233.
55. Rasko, D. A., Ravel, J., Okstad, O. A., Helgason, E., Cer, R. Z., Jiang, L., Shores, K. A., Fouts, D. A., Tourasse, N. J. & other authors (2004). The genome of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic Acids Res 32, 977-988.
56. Read, T. D., Peterson, S. N., Tourassee, N., Baillie, L. W., Paulsen, I. T., Nelson, K. E., Tettelin, H., Fouts, D. E., Eisen, J. A. & other authors (2003). The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423, 81-86.
57. Redmond, C., Baillie, L. W. J., Hibbs, S., Moir, A. J. G. & Moir, A. (2004). Identification of proteins in the exosporium of Bacillus anthracis. Microbiology 150, 355-363.
58. Steichen, C., Chen, P., Kearney, J. F. & Turnbough, C. L., Jr (2003). Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J Bacteriol 185, 1903-1910.
59. Steichen, C. T., Kearney, J. F. & Turnbough, C. L., Jr (2005). Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis. J Bacteriol 187, 5868-5876.
60. Steinmetz, M. & Richter, R. (1994). Easy cloning of mini-Tn10 insertions form the Bacillus subtilis chromosome. J Bacteriol 176, 1761-1763.
61. Sylvestre, P., Couture-Tosi, E. & Mock, M. (2002). A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol 45, 169-178.
62. Sylvestre, P., Couture-Tosi, E. & Mock M. (2005). Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the Bacillus anthracis exosporium. J Bacteriol 187, 5122-5128.
63. Vepachedu, V. R. & Setlow, P. (2005). Localization of SpoVAD to the inner membrane of spores of Bacillus subtilis. J Bacteriol 187, 5677-5682.
64. Welkos, S. L., Trotter, R. W., Becker, D. M. & Nelson, G. O. (1989). Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb Pathog 7, 15-35.
65. Welkos, S., Little, S., Friedlander, A., Fritz, D. & Fellows, P. (2004). The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147, 1677-1685.
66. Welkos, S., Friedlander, A., Weeks, S., Little, S. & Mendelson, I. (2002). In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 51, 821-831.
67. Welkos, S. L., Cote, C. K., Rea, K. M. & Gibbs, P. H. (2004). A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Methods 56, 253-265.